autoimmune diseases

Earendil Labs and WuXi Biologics Forge Strategic Alliance to Fast-Track Bispecific, Multispecific Antibodies, and ADCs

by
Microscopic view of bispecific antibodies and ADCs targeting cancer cells in a laboratory setting

“Earendil Labs, an AI-powered innovator in next-generation biologics, has partnered with WuXi Biologics, a leading global CRDMO, to advance multiple pipeline candidates including bispecific and multispecific antibodies as well as antibody-drug conjugates (ADCs) targeting cancer, autoimmune diseases, and other serious conditions. The deal leverages WuXi’s comprehensive development and GMP manufacturing expertise to speed up timelines, … Read more

Zura Bio to Participate in Upcoming Investor Conferences

by
Zura Bio management team preparing for investor meetings at biotech conferences in Miami, representing clinical-stage immunology advancements.

Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotech firm advancing innovative therapies for autoimmune and inflammatory diseases, has announced that its management team will engage with investors at two major conferences in Miami next week. The schedule includes a fireside chat at the Leerink Global Healthcare Conference on March 10, 2026, followed by one-on-one meetings … Read more